glp 1 consumers Using GLP-1s for Weight Loss Drive Lasting Changes in Retail Chart: 1 in 8 Americans

Experts say that the drop off is concerning, and that the medications aren't meant to be used as a quick fix

Segmental Analysis GLP-1 Receptor Agonist Market Analysis by Route of Administration Market Overview: Parenteral administration is expected to hold 80% of the GLP-1 receptor agonist market by 2026

Similarly, Wegovy and Zepbound also generate interest specifically for weight management treatments

2026 Roundup Review Updated May 2026 Best GLP-1 for Weight Loss Without Insurance: Top 5 Programs Compared We reviewed pricing, medications, FDA compliance, and patient experience across the leading cash-pay GLP-1 telehealth programs of 2026 to help you find the right fit

This is why advanced cardiometabolic evaluation may include blood pressure patterns, ApoB, LDL particle burden, lipoprotein(a), triglycerides, insulin resistance, inflammatory markers, body composition, and, when appropriate, imaging-based cardiovascular risk assessment